Evidence map›Paper›PMID 38938801›Full record

ArticleJACS Au2024

Mechanistic Rationale for Ketene Formation during Dabbing and Vaping.

Kaelas R Munger, Killian M Anreise, Robert P Jensen, David H Peyton, Robert M Strongin

Abstract read
In one paragraph

Article in JACS Au, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Cannabis concentrate vaping chemistry.Frontiers in toxicology · 2025
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kaelas R MungerDepartment of Chemistry, Portland State University, Portland, Oregon 97217, United States.
Killian M AnreiseDepartment of Chemistry, Portland State University, Portland, Oregon 97217, United States.
Robert P JensenFlorascience Inc., Milwaukie, Oregon 97222, United States.
David H PeytonDepartment of Chemistry, Portland State University, Portland, Oregon 97217, United States.ORCID https://orcid.org/0000-0001-5828-055X
Robert M StronginDepartment of Chemistry, Portland State University, Portland, Oregon 97217, United States.ORCID https://orcid.org/0000-0003-3777-8492

Funding

Toxicant Production and Mitigation in the Electronic-Cigarette Reaction VesselR01ES025257 · NIEHS · PORTLAND STATE UNIVERSITY · PI STRONGIN, ROBERT M · 2015 to 2019
$3.6M
Emerging Trends in the Chemistry of Cannabis Vaping and Toxicant EmissionsR16DA061946 · NIDA · PORTLAND STATE UNIVERSITY · PI ROBERT M STRONGIN · 2024 to 2026
$423k
NIDA NIH HHS R16 DA061946NIEHS NIH HHS R01 ES025257
6 · The paper itself

Abstract

Ketene is one of the most toxic vaping emissions identified to date. However, its high reactivity renders it relatively challenging to identify. In addition, certain theoretical studies have shown that realistic vaping temperature settings may betoo low to produce ketene. Each of these issues is addressed herein. First, an isotopically labeled acetate precursor is used for the identification of ketene with enhanced rigor in vaped aerosols. Second, discrepancies between theoretical and experimental findings are explained by accounting for the effects of aerobic (experimental) versus anaerobic (simulated and theoretical) pyrolysis conditions. This finding is also relevant to explaining the relatively low-temperature production of aerosol toxicants beyond ketene. Moreover, the study presented herein shows that ketene formation during vaping is not limited to molecules possessing a phenyl acetate substructure. This means that ketene emission during vaping, including from popular flavorants such as ethyl acetate, may be more prevalent than is currently known.

Identifiers

PMID38938801
PMCPMC11200222

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.